menu
    • menu

    Company profile for NephroDI Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff Sands and Janet Klein, recognized clinical and research leaders in kidney diseases. While NDI patients are now living longer lives with fewer cognitive deficits, the quality of their lives remains diminished. Drs. Sand and Klein were inve...
    NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff Sands and Janet Klein, recognized clinical and research leaders in kidney diseases. While NDI patients are now living longer lives with fewer cognitive deficits, the quality of their lives remains diminished. Drs. Sand and Klein were investigating the role of AMPK activators as a promising potential therapy to reduce urine volume in NDI patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NephroDI TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Philadelphia, PA 19103
    Telephone
    Telephone
    +1 857-891-0017
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nephrodi.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nephrodi-therapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NephroDI Therapeutics™ Founder Jeff M. Sands, M.D. Wins Award
    NephroDI Therapeutics™ Founder Jeff M. Sands, M.D. Wins Award

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067322/0/en/NephroDI-Therapeutics-Founder-and-CMO-Jeff-M-Sands-M-D-Receives-the-2025-Robert-W-Berliner-Award-for-Excellence-in-Renal-Physiology.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    NephroDI Receives Sound Bioventures Investment For NDI-5001 Development
    NephroDI Receives Sound Bioventures Investment For NDI-5001 Development

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901562/0/en/NephroDI-Therapeutics-Announces-Investment-by-Sound-Bioventures-to-Accelerate-Development-of-NDI-5001-as-a-Potential-First-in-Class-Therapy-for-Pediatric-Orphan-Kidney-Disease.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share
    NephroDI Therapeutics and MSRD partner to develop therapy for NDI
    NephroDI Therapeutics and MSRD partner to develop therapy for NDI

    23 Jun 2023

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/nephrodi-therapeutics-and-msrd-partner-to-develop-therapy-for-ndi/

    PHARMACEUTICAL TECHNOLOGY
    23 Jun 2023
    Share Share
    NephroDI Therapeutics Enters Agreement to Develop a First-in-Class
    NephroDI Therapeutics Enters Agreement to Develop a First-in-Class

    22 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230622006557/en

    BUSINESSWIRE
    22 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search